source
- White House withdraws Heidi Overton’s FDA commissioner nomination, raising uncertainty for agency’s futureThe White House pulled its nomination of Heidi Overton for FDA commissioner, a move that surprised members of the Senate health committee. Overton’s removal leaves the agency without a permanent h…
- BMS reports early Alzheimer’s psychosis data for Cobenfy showing reduced hallucinations but safety concerns remainAt the Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Boston, Bristol Myers Squibb presented early Phase 3 ADEPT data for KarXT, marketed as Cobenfy, in patients with Alzheimer’s disea…